171 related articles for article (PubMed ID: 34541912)
21. [Topical treatment of pigmentation disorders with cosmetic and pharmaceutical agents].
Kerscher M; Buntrock H
Hautarzt; 2020 Dec; 71(12):944-949. PubMed ID: 33146766
[TBL] [Abstract][Full Text] [Related]
22. The Therapeutic Use of Antioxidants for Melasma.
Babbush KM; Babbush RA; Khachemoune A
J Drugs Dermatol; 2020 Aug; 19(8):788-792. PubMed ID: 32845595
[TBL] [Abstract][Full Text] [Related]
23. New and emerging treatments for hyperpigmentation.
Alexis AF
J Drugs Dermatol; 2014 Apr; 13(4):382-5. PubMed ID: 24719055
[TBL] [Abstract][Full Text] [Related]
24. Oral tranexamic acid lightens refractory melasma.
Tan AWM; Sen P; Chua SH; Goh BK
Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of tranexamic acid in the treatment of adult melasma: An updated meta-analysis of randomized controlled trials.
Feng X; Su H; Xie J
J Clin Pharm Ther; 2021 Oct; 46(5):1263-1273. PubMed ID: 33959984
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
Zhu CY; Li Y; Sun QN; Takada A; Kawada A
Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
[TBL] [Abstract][Full Text] [Related]
27. Treatment of melasma: a review of less commonly used antioxidants.
Babbush KM; Babbush RA; Khachemoune A
Int J Dermatol; 2021 Feb; 60(2):166-173. PubMed ID: 32815582
[TBL] [Abstract][Full Text] [Related]
28. Topical treatments for melasma and postinflammatory hyperpigmentation.
Lynde CB; Kraft JN; Lynde CW
Skin Therapy Lett; 2006 Nov; 11(9):1-6. PubMed ID: 17075653
[TBL] [Abstract][Full Text] [Related]
29. Single blind, randomized, controlled trial of a lightening product with and without iontophoresis versus tretinoin and vehicle for hyperpigmentation.
Wanner M; Houston N; Javorsky E; Yuan M; Alora-Palli M; Kimball AB
J Drugs Dermatol; 2015 Jan; 14(1):13-8. PubMed ID: 25607903
[TBL] [Abstract][Full Text] [Related]
30. Lasers, lights, and compounds for melasma in aesthetics.
Kamal K; Heitmiller K; Christman M
Clin Dermatol; 2022; 40(3):249-255. PubMed ID: 34838653
[TBL] [Abstract][Full Text] [Related]
31. Natural ingredients for darker skin types: growing options for hyperpigmentation.
Alexis AF; Blackcloud P
J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s123-7. PubMed ID: 24002160
[TBL] [Abstract][Full Text] [Related]
32. A Randomized Trial of Oral Tranexamic Acid With Fluocinolone-Based Triple Cream Versus Fluocinolone Based Triple Cream Alone for the Treatment of Melasma.
Perveen S; Rubin A; Berger L; Xiong W; Waqas N; Sharif S; Rao B
J Drugs Dermatol; 2022 Mar; 21(3):321-322. PubMed ID: 35254752
[TBL] [Abstract][Full Text] [Related]
33. A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q-Switched 532-nm Nd:YAG Laser for Solar Lentigines.
Rutnin S; Pruettivorawongse D; Thadanipon K; Vachiramon V
Lasers Surg Med; 2019 Dec; 51(10):850-858. PubMed ID: 31302943
[TBL] [Abstract][Full Text] [Related]
34. Platelet-Rich Plasma in Melasma-A Systematic Review.
Sarkar R; Gupta M
Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
[TBL] [Abstract][Full Text] [Related]
35. What's New in Pigmentary Disorders.
Zubair R; Lyons AB; Vellaichamy G; Peacock A; Hamzavi I
Dermatol Clin; 2019 Apr; 37(2):175-181. PubMed ID: 30850040
[TBL] [Abstract][Full Text] [Related]
36. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
Malik F; Hanif MM; Mustafa G
J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
[TBL] [Abstract][Full Text] [Related]
37. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
[TBL] [Abstract][Full Text] [Related]
38. Skin lightening preparations and the hydroquinone controversy.
Draelos ZD
Dermatol Ther; 2007; 20(5):308-13. PubMed ID: 18045355
[TBL] [Abstract][Full Text] [Related]
39. Successful short-term and long-term treatment of melasma and postinflammatory hyperpigmentation using vitamin C with a full-face iontophoresis mask and a mandelic/malic acid skin care regimen.
Taylor MB; Yanaki JS; Draper DO; Shurtz JC; Coglianese M
J Drugs Dermatol; 2013 Jan; 12(1):45-50. PubMed ID: 23377327
[TBL] [Abstract][Full Text] [Related]
40. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma.
Mumtaz M; Chandio TH; Shahzad MK; Hanif N; Anwar S; Rafique S
J Coll Physicians Surg Pak; 2021 May; 31(5):502-505. PubMed ID: 34027858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
